section 8
on 07 Apr 2017
Last Applicant/ Owned by
MARTINSTRASSE 10-12
AACHEN
DE
52062
Serial Number
78070532 filed on 22nd Jun 2001
Registration Number
3134824 registered on 29th Aug 2006
Correspondent Address
Gary D. Krugman
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
[ (Based on Use in Commerce) Educational services, namely, providing seminars, informational events and/or workshops in the field of biotechnology, pharmacology, biochemistry, molecular biology, medical procedures, product research and development of medical devices and pharmaceutical preparations, research procedures, protein design diagnostics, molecular diagnostics, proteogenomic profiling, gen Read More
[ (Based on Use in Commerce) Educational services, namely, providing seminars, informational events and/or workshops in the field of biotechnology, pharmacology, biochemistry, molecular biology, medical procedures, product research and development of medical devices and pharmaceutical preparations, research procedures, protein design diagnostics, molecular diagnostics, proteogenomic profiling, gendiagnostics ]
01st Feb 2005
01st Feb 2005
(Based on 44(e)) Reagents for scientific or medical research use; diagnostic preparations or reagents for scientific or research use, biochemical reagents for scientific or medical research use; biochemical diagnostic preparations or reagents for scientific or research use
(Based on 44(e)) Pharmaceutical preparations, namely, pharmaceutical preparations derived from living organism proteins and peptides for treatment [ and diagnosis of tumors, cancer, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances, ] nervous diseases, [ diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, pain and epilepsy; pharmaceutical anti-inflammatory preparations; pharmaceutical nutriceutical preparations for the treatment of strokes, neuron damage, thrombotic diseases, tumors, cancer, heart disease including heart failure, circulation disorders, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances, nervous diseases, diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, pain and epilepsy; blood clotting test kits comprised of medical diagnostic reagents; ] medical and clinical diagnostic reagents for clinical or medical laboratory use
[ (Based on 44(e)) Laboratory devices for medical and pharmaceutical investigations, namely, portable medical devices for conducting medical diagnostic tests and blood specimen analysis of the human blood clotting system; medical devices, namely, coated catheters, medical stents, surgical implants comprising artificial materials; membranes intended for medical use, namely, filters for dialysis, hemofiltration ]
[ (Based on 44(e)) Computerized database management, namely, editing, evaluating and processing data for third parties ]
(Based on 44(e)) [ Database development for others; computer programming for others; performing chemical analyses for others; technical consultation in the field of biotechnology; services of a biotechnological laboratory, namely, conducting lab research for others in the field of drug research and development; pharmaceutical consulting, namely, providing pharmaceutical advice to others regarding governmental regulatory laws and practices, performing pre-clinical studies, quality control; ] preparation of expert opinions in the field of [ chemical engineering, biology, molecular biology, pharmacology, chemistry, bio-technology, bio-chemistry, ] product research and development of medical devices and pharmaceutical preparations; [ and molecular diagnostic services of a bio-chemist, namely, product research and development services for others in the area of gene expression analysis, namely, proteogenomic profiling, DNA-sequencing, drug target development and identifying, designing and analyzing therapeutic proteins; diagnostic services in the field of molecular science, comparative genome analysis, DNA-arrays including DNA-microarrays, creation of nucleic acid libraries, screening of nucleic acid libraries; ] performance of pre-clinical studies, namely, conducting and managing pre-clinical trials and studies of pharmaceutical, bio-technology and health care products; [ bio-chemical and biotechnological research and development for others, namely, bio-technological research and development regarding medical disease diagnosis and pharmacology, namely, prenatal diagnostic and identification of hereditary factors leading to diseases, identification of genes involved in the formation of cancer, identification of target molecules for cancer treatment; ] scientific research on and development of [ medical diagnostic equipment and ] pharmaceutical preparations and products for the treatment of [ tumors, cancer, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances, ] nervous diseases, [ diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, ] pain [ and epilepsy; scientific and technical consulting for others in the field of medical science and drug research, namely, identifying, designing, and developing drugs, specifically, therapeutic proteins, gene expression analysis, namely, proteogenomic profiling, DNA-sequencing, drug target development, identification and design; medical science research services for others, namely, prenatal diagnostics, molecular diagnostics, comparative genome analysis, DNA-arrays including DNA-microarrays, creating and screening of nucleic acid libraries, identifying hereditary factors leading to diseases, identifying genes involved in the formation of cancer, identification of target molecules for cancer treatment ]
No 78070532
No Service Mark
No S5775
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
07th Apr 2017 | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 |
29th Aug 2015 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
14th Mar 2013 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
14th Mar 2013 | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
14th Mar 2013 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
27th Feb 2013 | TEAS SECTION 8 & 15 RECEIVED |
27th Feb 2013 | REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED |
15th Nov 2006 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
29th Aug 2006 | REGISTERED-PRINCIPAL REGISTER |
06th Jun 2006 | PUBLISHED FOR OPPOSITION |